SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-012182
Filing Date
2016-08-11
Accepted
2016-08-11 07:03:04
Documents
69
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 611512
2 ex31-1.htm EX-31.1 20344
3 ex31-2.htm EX-31.2 20071
4 ex32-1.htm EX-32.1 8073
5 ex32-2.htm EX-32.2 8247
  Complete submission text file 0001493152-16-012182.txt   3508187

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20160630.xml EX-101.INS 559057
7 XBRL SCHEMA FILE aker-20160630.xsd EX-101.SCH 47815
8 XBRL CALCULATION FILE aker-20160630_cal.xml EX-101.CAL 56102
9 XBRL DEFINITION FILE aker-20160630_def.xml EX-101.DEF 145678
10 XBRL LABEL FILE aker-20160630_lab.xml EX-101.LAB 338487
11 XBRL PRESENTATION FILE aker-20160630_pre.xml EX-101.PRE 233608
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 161822980
SIC: 2835 In Vitro & In Vivo Diagnostic Substances